Maximus, Inc. (NYSE:MMS) Stock Holdings Cut by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. reduced its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 69.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 22,680 shares of the health services provider's stock after selling 51,115 shares during the quarter. Envestnet Asset Management Inc.'s holdings in Maximus were worth $1,693,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MMS. Vanguard Group Inc. increased its position in shares of Maximus by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after acquiring an additional 205,564 shares during the last quarter. Van Berkom & Associates Inc. grew its stake in Maximus by 8.5% during the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after purchasing an additional 98,264 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Maximus by 7.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock worth $74,700,000 after purchasing an additional 71,598 shares during the last quarter. Norges Bank purchased a new stake in Maximus during the 4th quarter worth approximately $71,443,000. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Maximus by 2.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock valued at $54,748,000 after purchasing an additional 16,772 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on MMS shares. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price for the company in a research report on Thursday, January 2nd.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares of the company's stock, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Maximus Stock Performance

MMS stock traded down $0.63 during midday trading on Thursday, reaching $66.34. The company had a trading volume of 517,201 shares, compared to its average volume of 555,938. The firm has a market capitalization of $3.75 billion, a PE ratio of 14.27 and a beta of 0.68. The stock has a 50 day moving average price of $67.66 and a 200 day moving average price of $74.14. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date is Thursday, May 15th. Maximus's payout ratio is 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.